Pharma Boulevard

Lier ·KBO/BCE: BE 0761.844.730

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-09-2025	61 d late	2025-00526648
31-12-2023	31-07-2024	30-09-2024	61 d late	2024-00497144
31-12-2022	31-07-2023	13-10-2023	74 d late	2023-00486436
31-12-2021	31-07-2022	31-10-2022	92 d late	2022-20517168

Metric	This company	Sector median	Position in the sector
Solvency	20.6%	20.4%	better than 50% of 1225 sector peers
Net result	€188k	€26k	better than 88% of 1224 sector peers
Equity	€386k	€142k	better than 74% of 1225 sector peers
Gross operating margin	€913k	€217k	better than 88% of 1223 sector peers
Staff costs	€537k	€163k	higher than 83% of 933 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.87M
Fixed assets	21/28	€464k
Tangible fixed assets	22/27	€464k
Financial fixed assets	28	€150
Current assets	29/58	€1.41M
Stocks & contracts in progress	3	€546k
Amounts receivable within one year	40/41	€747k
Cash & bank	54/58	€116k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.87M
Equity	10/15	€386k
Contributions / capital	10/11	€104k
Accumulated profits (losses)	14	€281k
Amounts payable	17/49	€1.49M
Amounts payable after one year	17	€402k
Amounts payable within one year	42/48	€1.06M
Trade debts payable within one year	44	€754k
Income statement
Gross operating margin	9900	€913k
Operating result	9901	€281k
Financial income	75	€1k
Financial charges	65	€35k
Result before taxes	9903	€248k
Income taxes	67/77	€60k
Net result for the period	9904	€188k
Result to be appropriated	9905	€188k

Summary